Abstract:Measurement of plasma concentrations of the dopamine metabolite, homovanillic acid (pHVA), is an indirect tool to assess changes in dopamine turnover. Levels of pHVA have been reported to decrease during treatment with conventional antidopaminergic, neuroleptics, with the decrement correlating with symptomatic improvement in schizophrenic symptoms. Clozapine, an atypical neuroleptic, is the only drug proved to be effective in treatment-refractory patients. However, the mechanism mediating this unique efficacy has not been fully elucidated. This study examined the effect of clozapine on pHVA concentrations in schizophrenic patients. Since clozapine potently binds to alpha2-adrenergic receptors, plasma norepinephrine (pNE) concentrations were also measured. Twenty-eight treatment-refractory schizophrenic patients (24 men, 4 women) were treated with clozapine (up to 600 mg/day) for 5 weeks, after a minimum 1-week drug-free period. Symptomatology and pHVA and pNE concentrations were measured at the last drug-free day and weekly for 5 weeks. Fourteen patients responded to clozapine treatment, while an equal number did not. Mean pHVA concentrations did not significantly change during treatment with clozapine. Although clozapine tended to lower pHVA concentrations in treatment responders, the effect was small and not significant. Clozapine treatment significantly raised pNE concentrations, but this did not differentiate responders from nonresponders to clozapine. These findings suggest that clozapine's effect on DA turnover is small and that clozapine may be effective in treatment-refractory schizophrenia by mechanisms other than, or in addition to, dopamine receptor blockade. However, since about one-third of NE is metabolized into HVA, the clozapine-induced increase in pNE may have overshadowed a possible lowering effect of clozapine on pHVA.

The Comparison of the Levels of Central Monoamine Neurotransmitters in Schizophrenia Before and after Clozapine Treatment

A Longitudinal Study of Monoamine Neurotransmitters in Positive and Negative Schizophrenia

Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia.

Effect of Neuroleptic Medication on Cerebrospinal Fluid Monoamine Metabolite Concentrations in Schizophrenia. Serotonin-dopamine Interactions As a Target for Treatment.

Relationship between the efficacy of clozapine and serum glutamate le vel

Metabolite differences in the medial prefrontal cortex in schizophrenia patients with and without persistent auditory verbal hallucinations: a <SUP>1</SUP>H MRS study

Metabolite differences in the medial prefrontal cortex in schizophrenia patients with and without persistent auditory verbal hallucinations: a 1 H MRS study

A Comparative Proteomics Analysis of Rat Mitochondria from the Cerebral Cortex and Hippocampus in Response to Antipsychotic Medications

The Effect of Olanzapine Treatment on Monoamine Metabolite Concentrations in the Cerebrospinal Fluid of Schizophrenic Patients

A Comparative Study of Serum Cholinesterase Activity Change and Clinical Effect after Patients Take Clozapine.

Comparative Study of Proton Magnetic Resonance Spectroscopy on Frontal Lobe Between Patients with Paranoid Schizophrenia and Patients with Bipolar Mania

SEROTONIN FUNCTION AND TREATMENT RESPONSE TO CLOZAPINE IN SCHIZOPHRENIC-PATIENTS

Effect of Clozapine on Levels of Blood Glucose and Insulin in Patients with Schizophrenia

Longitudinal follow-up of asymmetric changes by proton magnetic resonance spectroscopy in first-episode schizophrenia patients

Analysis the Relationship Between Polymorphism in the Serotonin 2A Receptor Gene and Variability among Individuals in Their Response to Clozapine

The effect of clozapine on immune-related biomarkers in schizophrenia patients

Comparation of Quetiapine and Clozapine in Treatment of Patients with First-Onset Schizophrenia

Abnormal Plasma Monoamine Metabolism in Schizophrenia and Its Correlation with Clinical Responses to Risperidone Treatment

The neurotransmitters activities and clinical symptoms in patients with schizophrenia: a correlation analysis

A Comparison Study on Efficacy and Safety of Quetiapine and Chlorpromazine in the Treatment of Schizophrenia

Clozapine Treatment and Its Effect on Neuroendocrine Responses Induced by the Serotonin Agonist, M-Chlorophenylpiperazine